Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Acetic Acid | HCID 176 | — |
| Reactant | Tetrabutylammonium Fluoride | HCID 2724141 | — |
| Reactant | HCID 69544092 | HCID 69544092 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | HCID 17858109 | HCID 17858109 | 95.1% |
Reaction Steps
To a solution of 3-t-butyldiphenylsilyloxy-1-{4-[1-(p-nitrobenzyloxycarbonyl)-piperidin-4-ylcarbamoyl]-1,3-thiazol-2-yl}azetidine (570 mg, 0.820 mmol) (obtained as described in Reference Example 51(5)) in anhydrous tetrahydrofuran (17 ml) were added successively acetic acid (56 μl, 0.984 mmol) and a 1.0M solution of tetra-n-butylammonium fluoride in tetrahydrofuran (984 μl, 0.984 mmol) in an ice bath, and the mixture was stirred in the ice bath for 1 hour. After checking the completion of the reaction, the reaction mixture was partitioned between ethyl acetate and saturated aqueous sodium hydrogencarbonate solution. The organic layer was washed successively with a saturated aqueous sodium hydrogencarbonate solution and a saturated aqueous sodium chloride solution, dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure. The residue was purified by chromatography on a silica gel column using n-hexane:ethyl acetate (1:3)→ethyl acetate:methanol (95:5) as the eluant to afford 3-hydroxy-1-{4-[1-(p-nitrobenzyloxycarbonyl)-piperidin-4-ylcarbamoyl]-1,3-thiazol-2-yl}azetidine (360 mg, yield 95%) as a white solid.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07001897B2 |
|---|
| Source dataset | uspto-grants-2006_02 |
|---|
| ORD ID | ord-af9383dd02124a77b1395ccfee17c7f2 |
|---|
| Source note | uspto-grants-2006_02 |
|---|